The importance of major and minor ECG abnormalities at baseline for subsequent risk of death from coronary heart disease, cardiovascular diseases and all causes was analyzed for middle-aged white men from the Chicago Peoples Gas Company, Chicago Western Electric Company and Chicago Heart Association Detection Project in Industry studies. Univariate analysis showed that in all three studies, men with major ECG abnormalities had death rates considerably higher than those with normal ECGs. When baseline age, diastolic pressure, serum cholesterol, relative weight and number of cigarettes per day were taken into consideration in multivariate analysis, ECG abnormalities retained significant relationship to the three death end points. Findings from the Chicago Western Electric Company and Chicago Heart Association studies showed independent relationship between minor ECG abnormalities and the three death end points. In the Chicago Peoples Gas Company (20-year follow-up) and in the Chicago Western Electric Company (17-year follow-up), when the deaths were divided into those that occurred within the first 10 years of follow-up and those that occurred more than 10 years after entry, the association between ECG abnormalities and mortality held for both the first and second decades of follow-up. Overall, findings from this study demonstrate an independent relationship between ECG abnormalities and death from coronary heart disease, cardiovascular disease and all causes.
ties relate to risk of death from CHD, cardiovascular diseases (CVD) and all causes independent of the established major risk factors. The ECG abnormalities are classified as major and minor, based on the criteria of the Pooling Project. 8 Findings from three longitudinal population studies are presented: the Chicago Peoples Gas Company,"' the Chicago Western Electric Company"7 and the Chicago Heart Association Detection Project in Industry"8 19 studies.
Materials and Methods
The Chicago Peoples Gas Company study is a longterm prospective investigation of the natural history, epidemiology and etiology of the adult CVD in 1465 men ages 40-59 years on January 1, 1958 . A description of this study has been published. 18 The cohort used here involves 1258 white men who met the criteria for the Pooling Project and had complete baseline data on all relevant variables. Mortality findings are based on 20 years of follow-up. Vital status was known for all, and cause of death was determined by reviewing the death certificates according to the seventh revision of the ICDA classification.
The Chicago Western Electric Company study is a prospective investigation of CHD that was started in the fall of 1957 among men ages 40-55 years employed by the Hawthorne Works of the Western Electric Company in Chicago. A randomly selected group of men employed for longer than 2 years as of 1957 was invited to participate. Sixty-seven percent of those invited agreed to participate and underwent physical 146 examination in late 1957 or 1958. Details of this study have been described."7 The cohort for the present investigation consists of 1893 white men who met the criteria for the Pooling Project and had complete initial examination data on all relevant variables. In this group, 3% were lost to 17- year mortality follow-up before December 31, 1974. Data collected on these latter persons were included in the analyses. Cause of death was classified by reviewing death certificates and was based on the eighth revision of the ICDA classification.
The Chicago Heart Association Detection Project in Industry is a cross-sectional and prospective study of 39,665 young adult and middle-aged men and women, black and white, who were screened from November 1967 to January 1973 in 84 cooperating companies and organizations in Chicago. Those screened made up 55% of all people employed by these industries.18 19 As of December 1978, all of the almost 40,000 screened were 5 years beyond the date of the original survey, with vital status ascertained for 83%. The data used in this study are for 8053 white men ages 40-59 years and free of definite myocardial infarction at entry, with complete baseline data on all relevant variables, and with known vital status for a follow-up of 2-135 months (average 62 months). Again, cause of death was determined by the method used in the Western Electric Company study.
In the Chicago Peoples Gas and Chicago Western Electric studies, 12-lead ECGs were recorded, and tracings were read according to the Minnesota code. 20 In the Chicago Heart Association Detection Project in Industry study, the ElectroCardioAnalyzer (ECA) and five-, sixor 12-lead ECGs were used at different baseline examination periods. Tracings were obtained according to one of these procedures: (1) five-lead ECG; (2) six-lead ECG, (3) 12-lead ECG; (4) first examined by ECA; if ECA is normal, use ECA only; otherwise use 12-lead ECG; (5) first examined by ECA; if ECA is normal, use five-lead ECG, if ECA is abnormal, use 12-lead ECG. All ECGs were read using the criteria and forms of the 1960-1962 National Health Examination Survey, U.S. Public Health Service.2' Tracings with any abnormalities were later identified and reclassified according to Minnesota code. In all studies, ECG abnormalities were divided into major and minor using the criteria of the Pooling Project8 (table 1) . Persons with both major and minor abnormalities were classified as major.
The relationship between major or minor ECG abnormalities and long-term mortality was examined in both univariate and multivariate analyses.
In the univariate analyses, to assess the relationship of the ECG abnormalities to mortality, relative risk and absolute excess risk was calculated. Relative risk was computed as P, (1000.0 -P2)/P2 (1000.0 -P,) and the absolute excess risk was computed by P, -P2, where P, is the age-adjusted mortality rate per 1000 in those with abnormal ECGs and P2 is the mortality rate in those with normal ECGs.
For the Gas Company and Western Electric Company studies, the age-adjusted rates were calculated by Abbreviations: AV = atrioventricular; IV = interventricular; WE = Western Electric; CHA = Chicago Heart Association.
averaging the corresponding mortality rates for the two 10-year age groups (40-49 and 50-59 years). The mortality rates for the Chicago Heart Association Detection Project in Industry study were adjusted by averaging the rates for the four 5-year age groups from 40-59 years. In the multivariate analyses, the Cox regression model (Dyer A: unpublished data)22 was used. The Cox regression model uses time until death (survival time) as the principal variable, with the risk factors regarded as covariates of survival time. In estimating the measurements of the model, the time for each person was either time from study entry until death from any cause or time from entry until the cutoff date for analysis for a person still alive at that point. In the Chicago Western Electric Company study, time from study entry until loss to follow-up was also considered. Estimation of the coefficients was done by the method of maximum likelihood (Dyer A: unpublished data).22 The relationship of major or minor ECG abnormalities to mortality was assessed 147 VOL 65, No 1, JANUARY 1982 by testing the hypothesis that the coefficient corresponding to these variables is equal to zero. In multivariate analyses, adjustment was made for age, diastolic pressure, serum cholesterol, relative weight and cigarettes per day.
Results Table 2 is a summary of baseline values for age, diastolic blood pressure, serum cholesterol, relative weight, number of cigarettes per day and ECG findings for each of the five ECG groups determined by the ECG screening procedure used in the Chicago Heart Association Detection Project in Industry. The proportions of ECG abnormalities were generally the same among the groups, except for the higher proportions among those who were given either sixor 12lead ECGs. The 12-lead ECG group tends to show a higher percentage of major ECG abnormalities; except for the five-lead ECG group, the differences between the 12-lead ECG group and the other three groups are statistically significant. The 12-lead method could have permitted more thorough characterization than the other methods and therefore detected more major abnormalities. Differences among the five groups for the other variables were small. Table 3 presents 5-year mortality rates for each mortality end point by ECG abnormalities at baseline for each of the five groups. In all ECG groups, men with either major or minor ECG abnormalities had CHD, CVD and all-causes death rates higher than those with normal ECGs. Because of the relatively small number of persons with either major or minor ECG abnormalities, the correspondingly small number of deaths among them, the similar risk factor patterns (table 2) and the same general relationship of ECG abnormalities to mortality among the five groups, the analyses in the Chicago Heart Association Detection Project in Industry are based on data from the pooling of the five ECG groups. To further assure that the five ECG groups can be pooled for multivariate analyses, Cox regression with and without four indicator variables for separating the five groups and four cross product terms between them and the ECG variable were computed (table 3) . All the differences for the log-likelihoods between the two models are not significant. Thus, the pooling of these five groups is appropriate.
Major ECG Abnormalities Table 4 displays univariate data on presence of major ECG abnormalities at entry and long-term mortality by cause for the three cohorts. Mortality rates for each end point for each cohort were higher for men with major ECG abnormalities at baseline compared with men who had normal ECGs. In the Western Electric and Gas Company studies, men with major ECG abnormalities experienced CHD, CVD and all-causes death rates 1.73-3.42 times higher than those with normal ECGs. In the Chicago Heart Association Detection Project in Industry these rates were 4.16-7.28 times higher. In terms of absolute excess risk, those in the Western Electric and Peoples Gas Company studies with major ECG abnormalities had 81-230 extra chances per 1000 of dying in 17 and 20 years, respectively, compared with those who had no ECG abnormalities. For those in the Chicago Heart Association cohort with major ECG abnormalities, this extra risk was about 75 per 1000 in 5 years. Table 5 shows regression coefficients, standard errors and t values for the three end points for each of the studies, based on the Cox regression model. With control for age, diastolic pressure, serum cholesterol, cigarette smoking and relative weight, major ECG abnormalities were associated with a highly significant independent likelihood of subsequent CHD, CVD and all-cause mortality in each of the studies.
Given the long follow-up in the Chicago Peoples Gas and in the Western Electric Company studies, an analysis was done to determine if the association between major ECG abnormalities and risk of death prevailed both during earlier and later years. Table 6 148 CIRCULATION Major  321  32  100  20  62  18  56  Minor  169  9  53  7  41  5  30  Normal  3102  68  22  22  7  15  5  6-lead  Major  97  15  155  12  124  11  113  Minor  231  15  65  10  43  9  39  Normal  1044  25  24  17  16  16  15  12-lead  Major  43  4  93  4  93  4  93  Minor  37  3  81  1 shows mortality rates and presence of major ECG abnormalities at baseline by the length of follow-up. Deaths were divided into those that occurred within the first 10 years of follow-up and those that occurred more than 10 years after study entry. In the Chicago Western Electric Company study, men lost to followup within the first 10 years (32 men) were excluded in the computation of the 10-17-year rates. For deaths 149 from CHD and CVD, except for CHD mortality in the Gas Company cohort, relative risk for men with baseline major ECG abnormalities was well above unity for both time periods. It was greater for the first 10 years of follow-up than for more than 10 years after study entry; for example, for the Western Electric men for CHD, a ratio of 4.14 vs 3.15. However, the absolute excess mortality attributable to the presence of major ECG abnormalities at entry tended to be similar for the two periods.
Minor ECG Abnormalities Table 7 presents univariate findings on minor ECG abnormalities at baseline and long-term mortality rates by cause for the three studies. In the Chicago Western Electric Company and in the Chicago Heart Association Detection Project in Industry, CHD, CVD and all-causes death rates were generally higher for men with minor ECG abnormalities than for those with normal ECGs. In the Chicago Peoples Gas Company study, this was also the case for all-causes and all-CVD mortality, but not for CHD death. Table 8 gives estimated regression coefficients, their standard errors, and t values for minor ECG abnormalities, for the three mortality end points, for the three cohorts, based on the Cox regression analyses. For the Chicago Western Electric Company and the Chicago Heart Association Detection Project in In- 150 CIRCULATION ECG ABNORMALITIES AND RISK OF DEATH/Cedres et al. dustry, for each of the end points, the estimated coefficients were significantly different from zero. In the Chicago Peoples Gas Company, these abnormalities were not significantly related to CVD and all-causes mortality. Because of the small number of deaths, multivariate analysis was not done for the CHD end point in the Chicago Peoples Gas Company cohort. Table 9 shows mortality rates from CHD, CVD and all causes by length of follow-up for men with minor and with no ECG abnormalities at entry for the Chicago Peoples Gas Company and the Chicago Western Electric Company studies. In this latter study, the 39 men lost to follow-up were excluded in the computation of the 10-17-year rates. Except for the CHD mortality rates for the Peoples Gas Company cohort, all risk ratios were well above unity for both time periods. The ratios were larger for the first than for the second time period, but absolute excess risk tended to be about as large or larger for the second.
Discussion
In these three studies of middle-aged white men, univariate analyses indicated that men with major ECG abnormalities at baseline experienced death from CHD, CVD and all causes higher than those with normal ECGs. When baseline age, diastolic pressure, serum cholesterol, relative weight and cigarette smoking were considered in multivariate analyses, major ECG abnormalities retained a significant relationship to the three death end points. Furthermore, findings in the Chicago Western Electric Company and the Chicago Heart Association Project in Industry showed an independent relationship between minor ECG abnormalities and the three death end points. Abbreviations: CVD = cardiovascular disease; CHD = coronary heart disease. Few studies have been done to evaluate the independent relationship between ECG abnormalities and subsequent mortality. The 5-year follow-up of the Whitehall study showed significant association between any ECG abnormality and CHD mortality independent of systolic blood pressure and serum cholesterol.'8 The Framingham study reported significant association between the ECG pattern of left ventricular hypertrophy and death from CHD, independent of systolic blood pressure, serum cholesterol and cigarette smoking, for men ages 45-74 years." Data from southern Europe and U.S. railway workers showed an association between negative T waves, ventricular conduction defects, atrial fibrillation and hard CHD (CHD death and nonfatal infarct) independent of systolic blood pressure, serum cholesterol, cigarette smoking and body mass index (Blackburn H: unpublished data).
Findings from the present study extend these observations on the role of ECG abnormalities as independent risk factors for death from CVD diseases and all causes. Whether each major or minor ECG abnormality also increases risk of subsequent mortality must be clarified.
Data from the Chicago Peoples Gas Company and the Chicago Western Electric Company studies showed that the association between ECG abnormalities, in particular major abnormalities, and mortality held for both the first and second decades of follow-up. It was slightly stronger, based on relative risks, for deaths during the first period of follow-up. These results are consistent with the findings reported by the Whitehall study; that is, ECG abnormalities were powerful predictors for and middle term.'0 CHD incidence in the short
The results of this study raised a question as to whether the ECG should be used as a screening tool for heart disease in epidemiologic investigations, particularly because it is time-consuming and expensive. This question can be answered only by studying whether a large proportion of persons do not have any of the risk factors (smoking, hypertension and hypercholesterolemia) but have an abnormal ECG reading and by ascertaining, if this is the case, whetber those with abnormal ECGs have a high risk of mortality from CHD, CVD or all causes. This issue remains to be explored in the data base of the three Chicago studies.
More studies need to be done to determine the independent significance for mortality of the serial changes over time in the ECG. Systematic study of these questions can help to define in greater depth the significance of various ECG abnormalities, seen at baseline or developing de novo, and the value of estimating the transitional probability from one status to another over a given period. This in turn can create a data base for rational estimation of optimal frequency of ECG reexamination, to detect status change that has independent prognostic significance.
